Suchergebnisse - "Cost-effectiveness"

PubPharm (27.167)

61

Cost-effectiveness of axicabtagene ciloleucel for adult patients with relapsed or refractory follicular lymphoma in the United States

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2024

von Oluwole, O. | Ray, M. | Rosettie, K. | +5

62

Cost-Effectiveness Analysis of Innovative Therapies for Patients with Non-Alcoholic Fatty Liver Disease

enthalten in: Journal of market access & health policy | 2024

von Pochopien, M. | Dziedzic, J. | Aballea, S. | +4

63

Efficacy, safety and cost-effectiveness of 5-fluorouracil versus interferon α-2b as adjuvant therapy after surgery in ocular surface squamous neoplasia in a southern European tertiary hospital

enthalten in: International ophthalmology | 2024

von San Román Llorens, J. | Fernández-Gurria, M. | Artaechevarria Artieda, J. | +3

64

Cost-Effectiveness of a Multicomponent Primary Care Intervention for Hypertension

enthalten in: Journal of the American Heart Association | 2024

von Chay, J. | Jafar, T. | Su, R. | +3

65

Cost-effectiveness analysis of fluticasone furoate/umeclidinium bromide/vilanterol and umeclidinium bromide/vilanterol in the management of moderate and severe COPD in China

enthalten in: Respiratory medicine | 2024

von Zhou, Y. | Duan, S. | Zhang, L. | +1

66

Green alternatives to petroleum-based plastics : production of bioplastic from Pseudomonas neustonica strain NGB15 using waste carbon source

enthalten in: Environmental science and pollution research international | 2024

von Baltacı, N. | Baltacı, M. | Görmez, A. | +1

67

Calculating the cost of medication errors : A systematic review of approaches and cost variables

enthalten in: BMJ open quality | 2024

von Ranasinghe, S. | Nadeshkumar, A. | Senadheera, S. | +1

68

Health state utility estimates for value assessments of novel treatments in Huntington's disease : a systematic literature review

enthalten in: Health and quality of life outcomes | 2024

von Sawant, R. | Paret, K. | Petrillo, J. | +4

69

Health state utility estimates for value assessments of novel treatments in Huntington’s disease: a systematic literature review

enthalten in: Health and quality of life outcomes | 2024

von Sawant, R. | Paret, K. | Petrillo, J. | +4

70

Filgrastim biosimilar (EP2006) : A review of 15 years' post-approval evidence

enthalten in: Critical reviews in oncology/hematology | 2024

von Gascón, P. | Harbeck, N. | Rapoport, B. | +4